Allergic conjunctivitis: an update on diagnosis and management

Current Opinion in Allergy and Clinical Immunology
Terrence P O'Brien

Abstract

The focus of this review is to provide a logical paradigm for the diagnosis and treatment of ocular allergies, with a focus on seasonal allergic conjunctivitis (SAC) and perennial allergic conjunctivitis (PAC). Several classes of topical medications are currently available for the management of ocular allergies, including: lubricating agents, vasoconstrictors, antihistamines, mast cell stabilizers, and topical corticosteroids. SAC and PAC make up the vast majority of ocular allergy cases. A proactive approach to these diseases, anticipating the regional spring and fall allergen spikes, is needed for optimally managing these disorders. A multifaceted treatment regimen comprising patient education, lifestyle modification, and topical medications (such as antihistamines and/or mast cell stabilizers and corticosteroids) may be required in order to manage ocular allergies effectively. The appropriate treatment paradigm is based on the severity of the patients' signs and symptoms. For moderate-to-severe cases, especially chronic vernal keratoconjunctivitis, atopic keratoconjunctivitis, and giant papillary conjunctivitis, comanagement with an ophthalmologist is recommended.

References

Jan 1, 1990·Archives of Ophthalmology·M B AbelsonL M Smith
Jan 1, 1984·Allergy·C MöllerS Dreborg
Oct 6, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·M B Abelson
Dec 12, 2000·The Journal of Allergy and Clinical Immunology·L Bielory
Jun 18, 2003·Clinical Therapeutics·David G ShulmanAdrienne Graves
Jul 5, 2003·Current Medical Research and Opinion·G W CanonicaR Hermann
Oct 2, 2003·Journal of Glaucoma·James C TsaiJames W Pichert
Feb 24, 2004·Ophthalmic Epidemiology·Andrew D PittAnthony J Bron
Jan 8, 2005·The Journal of Allergy and Clinical Immunology·Santa Jeremy Ono, Mark B Abelson
Nov 2, 2005·Health and Quality of Life Outcomes·Michael AlexanderLinda Abetz
Oct 25, 2006·International Ophthalmology Clinics·Mitchell H Friedlaender
Nov 15, 2006·Cornea·Ashley BehrensUNKNOWN Dysfunctional tear syndrome study group
Feb 20, 2008·Immunology and Allergy Clinics of North America·Leonard Bielory
Feb 20, 2008·Immunology and Allergy Clinics of North America·Leonard Bielory, Mitchell H Friedlaender
Jul 31, 2008·The Journal of Allergy and Clinical Immunology·Dana V WallaceUNKNOWN Joint Council of Allergy, Asthma and Immunology
Nov 27, 2008·Allergy·S CaimmiP Demoly
May 22, 2010·American Journal of Ophthalmology·Thomas T MacejkoUNKNOWN Bepotastine Besilate Ophthalmic Solutions Clinical Study Group
Apr 7, 2011·Current Opinion in Allergy and Clinical Immunology·Juliane KöberleinCorinna Schaffert
Jul 26, 2011·Current Opinion in Allergy and Clinical Immunology·Nelson Rosario, Leonard Bielory
Nov 1, 2011·The Journal of Allergy and Clinical Immunology·F Estelle R Simons, Keith J Simons
Nov 10, 2011·Acta Ophthalmologica·Brett P BieloryLeonard Bielory
Sep 20, 2012·Allergy and Asthma Proceedings·Edward J MeierUNKNOWN Bepotastine Besilate Ophthalmic Solutions Study Group
Mar 15, 2013·Allergy and Asthma Proceedings·Warner W CarrUNKNOWN Bepotastine Besilate Ophthalmic Solution 1.5% (Bepreve) Study Group

❮ Previous
Next ❯

Citations

May 7, 2015·Expert Opinion on Pharmacotherapy·Mark B AbelsonLisa M Smith
Mar 26, 2014·Expert Opinion on Emerging Drugs·Erminia RidoloGiorgio Walter Canonica
Jun 4, 2015·Current Medical Research and Opinion·Lian-Qun WuRui-Li Wei
Jan 11, 2017·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Gail TorkildsenFrancis S Mah
Feb 9, 2017·Clinical and Molecular Allergy : CMA·Maria Teresa VenturaGiorgio Walter Canonica
Dec 2, 2017·Journal of Cutaneous Medicine and Surgery·Melinda GooderhamKim Papp
Dec 14, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chuan-Hui KuoSanta J Ono
Oct 13, 2017·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·K SchröderU Pleyer
Jan 16, 2016·Therapeutic Advances in Chronic Disease·Stacey AckermanPaulo J Gomes
Jul 19, 2018·Current Opinion in Allergy and Clinical Immunology·Hadas Ben-Eli, Abraham Solomon
Mar 11, 2019·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Fang-Yu LiuI-Jong Wang
Aug 15, 2014·Current Opinion in Allergy and Clinical Immunology·Paulo J Gomes
Mar 17, 2020·Oman Journal of Ophthalmology·Dora Hamad AlHarkan
Sep 12, 2020·Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association·Peike HuHailong Ni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

The Journal of Allergy and Clinical Immunology
Takechiyo YamadaShigeharu Fujieda
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Minoru Okuda
© 2022 Meta ULC. All rights reserved